Dynamic changes in 1H-MR relaxometric properties of cell-internalized paramagnetic liposomes, as studied over a

Maarten B Kok1, Gustav J Strijkers, Klaas Nicolay

  • 1Biomedical NMR, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.

Insights

Magnetic resonance imaging (MRI) needs amplification for detecting molecular markers. This study tracks gadolinium (Gd3+) liposomes in cells over 5 days, finding significant loss and reduced MRI signal, suggesting Gd3+ release.

Area of Science:

  • Biomedical Imaging
  • Nanotechnology
  • Biochemistry

Background:

  • MRI sensitivity is limited for detecting low-level molecular markers.
  • Amplification strategies are crucial for enhancing MRI sensitivity.
  • Paramagnetic liposomes and receptor-mediated endocytosis are promising amplification methods.

Purpose of the Study:

  • To investigate the long-term fate of cell-internalized gadolinium (Gd3+)-containing liposomes.
  • To evaluate the relaxometric properties of internalized contrast material over 5 days.
  • To understand the stability and behavior of Gd3+ within cells after liposome delivery.

Main Methods:

  • Utilized integrin-targeted paramagnetic liposomes with high Gd3+ payload.
  • Monitored liposome uptake and intracellular delivery over 24 hours.
  • Assessed relaxometric properties (R1 and R2) of internalized Gd3+ over a 5-day period.

Main Results:

  • A significant loss of Gd3+ (approx. 25%) occurred within 24 hours post-delivery.
  • Reductions in R1 (65%) and R2 (77%) enhancements were observed, indicating lower relaxivities.
  • Gd3+ release from chelates and sequestration in an MR-silent state is proposed.
  • Non-targeted liposomes showed substantial Gd3+ release over 5 days.

Conclusions:

  • Cellular internalization of Gd3+-liposomes leads to substantial loss of contrast material and reduced MRI signal over time.
  • The observed decrease in relaxivity suggests gradual Gd3+ release and sequestration within cells.
  • These findings have implications for the design and application of liposomal contrast agents in molecular MRI.

Related Concept Videos